The Bst Case
AbstractRecombinant Bovine Somatotropin (rBST) is a milk production enhancer, a product of industrial microbiology. First approved for commercial sale in the United States (U.S.) by the Food and Drug Administration (FDA) in 1994, rBST has been immersed in controversy since the early 1980s. Conflicts among major players with interests in rBST have shaped the product's image and influenced its use. Players with interests in the product include government agencies, Monsanto Corporation (the first firm approved to sell rBST), other firms seeking commercial approval to sell rBST, dairy farmers, and consumers.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by University of Wisconsin Madison, AAE in its series Staff Papers with number 397.
Date of creation: Jun 1996
Date of revision:
Contact details of provider:
Postal: University of Wisconsin, Dept. of Agricultural and Applied Economics, 427 Lorch Street, Madison, WI 53706
Web page: http://www.aae.wisc.edu/
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Thompson, Paul B., 1996. "Food Labels and the Ethics of Consent," Choices, Agricultural and Applied Economics Association, vol. 11(1).
- Runge, C. Ford & Jackson, Lee Ann, 1999. "Labeling, Trade And Genetically Modified Organisms (Gmos): A Proposed Solution," Working Papers 14402, University of Minnesota, Center for International Food and Agricultural Policy.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Thomas Krichel).
If references are entirely missing, you can add them using this form.